ArticleMedical oncology (Northwood, London, England)2025

PD-L1 targeting in triple negative breast cancer: in silico and in vitro validation of wasp venom peptide MP-1.

Azra Sakhawat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.